As the use of artificial intelligence (AI) takes hold in Asia’s healthcare industry, researchers are collecting detailed health profiles of citizens and using the data to test treatments, monitor adverse drug reactions in patients, detect the risk of cognitive issues in children... Read More
Driven by the needs of its growing number of aging adults, the Japanese healthcare industry is rapidly adopting digital technology to bolster the work of physicians, nurses and medical researchers. Increasingly, Japanese doctors are digitizing medical records and consolidating metadata health data... Read More
This article was originally published on MedTech Intelligence. The use of artificial intelligence in healthcare is accelerating rapidly, as devices and products that mimic human learning and behavior are on track to get regulatory approval in the United States, Europe and increasingly,... Read More
The coronavirus will affect the medical supply chain coming from China. Various reports indicate that while 50% of Chinese factories are now open, only about half of these are actually producing medical products. Many Chinese employees are still working from home. While... Read More
With the COVID-19 virus shaking global markets and economies, anti-viral drug developers around the world are increasing efforts to develop treatments for the disease. Western pharmaceutical firms and research organizations have launched accelerated research and testing programs for novel coronavirus vaccines. Among... Read More
With the incidence of non-communicable diseases rising in Malaysia and as household incomes grow, the Southeast Asian nation presents fertile ground for both the pharmaceutical and medical device industries. According to analyst GlobalData, the medical device market in the country, worth $1.28... Read More
This article was originally published on Medtech Intelligence. Artificial intelligence devices or products, known popularly as AI, imitate intelligent behavior or mimic human learning and reasoning. In its more basic forms, artificial intelligence has been used in the healthcare field to perform... Read More
Fueled by a lack of access to preventative eye care and a dearth of public vision screening programs, myopia, and other ophthalmologic conditions are on the rise in East Asia. In one city in China, a 15-year study completed in 2015 found... Read More
As China’s drug market grows exponentially, more foreign API, excipient and drug packaging material companies look to sell their products in China. In August 2016, to simplify the drug review procedure, the former CFDA announced that the review and approval of APIs,... Read More
Systematic evaluations of the effects of health technologies in Japan, China, and South Korea conducted over the past three years are showing success in determining the clinical benefits and cost-effectiveness of widely used drugs, adjusting pricing of drugs and medical devices and... Read More